Skip to main content
. 2000 Jan;49(1):39–48. doi: 10.1046/j.1365-2125.2000.00113.x

Table 1.

The demographic characteristics and baseline laboratory values for the trial population. The sample included 402 (98%) Caucasians, 1 black, 3 Orientals, and 6 patients of other ethnic origin. Of the trial population, 23% (n = 95) of patients received dopamine agonists, 87% reported drinking caffeine (n = 358), 57% (n = 234) reported drinking alcohol and 10% (n = 42) were smokers. All data are given as median values (minimum—maximum value).

graphic file with name bcp0049-0039-t1.jpg